Development and validation of a noninvasive prediction model of autoimmune hepatitis in patients with liver diseases

References

• Liu HL, Yang YF, Xiong QF, et al. Etiological analysis of hepatopathy of unknown etiology in 470 cases undergoing routine liver biopsy examination. Zhonghua Gan Zang Bing Za Zhi. 2019;27:885–889.
   PubMedGoogle Scholar
• Johnson PJ, McFarlane IG. Meeting report: international autoimmune hepatitis group. Hepatology 1993;18(4):998–1005. doi: 10.1002/hep.1840180435.
   PubMed Web of Science ®Google Scholar
• Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31(5):929–938. doi: 10.1016/s0168-8278(99)80297-9.
   PubMed Web of Science ®Google Scholar
• Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48(1):169–176. doi: 10.1002/hep.22322.
   PubMed Web of Science ®Google Scholar
• Qiu D, Wang Q, Wang H, et al. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. J Hepatol. 2011;54(2):340–347. doi: 10.1016/j.jhep.2010.06.032.
   PubMed Web of Science ®Google Scholar
• Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases. Hepatology 2020;72(2):671–722. doi: 10.1002/hep.31065.
   PubMed Web of Science ®Google Scholar
• Harrington C, Krishnan S, Mack CL, et al. Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis. Hepatology 2022;76(6):1862–1879. doi: 10.1002/hep.32591.
   PubMed Web of Science ®Google Scholar
• Sripongpun P, Pongpaibul A, Charatcharoenwitthaya P. Value and risk of percutaneous liver biopsy in patients with cirrhosis and clinical suspicion of autoimmune hepatitis. BMJ Open Gastroenterol. 2021;8(1):e000701. doi: 10.1136/bmjgast-2021-000701.
   Web of Science ®Google Scholar
• Caldwell S, Northup PG. Bleeding complication with liver biopsy: is it predictable? Clin Gastroenterol Hepatol. 2010;8(10):826–829. doi: 10.1016/j.cgh.2010.06.010.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang J, Wang H, et al. Develop and validate a novel online AIHI-nomogram to predict severe liver inflammation in patients with autoimmune hepatitis. Ann Hepatol. 2023;28(6):101134. doi: 10.1016/j.aohep.2023.101134.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang J, Wang H, et al. An easy-to-use AIHF-nomogram to predict advanced liver fibrosis in patients with autoimmune hepatitis. Front Immunol. 2023;14:1130362. doi: 10.3389/fimmu.2023.1130362.
   PubMed Web of Science ®Google Scholar
• Llovet LP, Gratacós-Ginès J, Téllez L, et al. Noninvasive prediction of outcomes in autoimmune hepatitis-related cirrhosis. Hepatol Commun. 2022;6(6):1392–1402. doi: 10.1002/hep4.1889.
   PubMed Web of Science ®Google Scholar
• Heus P, Reitsma JB, Collins GS, et al. Transparent reporting of multivariable prediction models in journal and conference abstracts: TRIPOD for abstracts. Ann Intern Med. 2020;173:42–47. doi: 10.7326/M20-0193.
   Web of Science ®Google Scholar
• Snell KIE, Levis B, Damen JAA, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2023;381:e073538. doi: 10.1136/bmj.g7594.
   PubMed Web of Science ®Google Scholar
• James MT, Pannu N, Hemmelgarn BR, et al. Derivation and external validation of prediction models for advanced chronic kidney disease following acute kidney injury. JAMA 2017;318(18):1787–1797. doi: 10.1001/jama.2017.16326.
   PubMed Web of Science ®Google Scholar
• Fenlon C, O’Grady L, Doherty ML, et al. A discussion of calibration techniques for evaluating binary and categorical predictive models. Prev Vet Med. 2018;149:107–114. doi: 10.1016/j.prevetmed.2017.11.018.
   PubMed Web of Science ®Google Scholar
• Jacobs JP, Shahian DM, O’Brien SM, et al. Assessing the performance of risk models with discrimination and calibration. Ann Thorac Surg. 2023;115(1):282–286. doi: 10.1016/j.athoracsur.2022.05.032.
   PubMed Web of Science ®Google Scholar
• Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112(1):18–35. doi: 10.1038/ajg.2016.517.
   PubMed Web of Science ®Google Scholar
• Sebode M, Weiler-Normann C, Liwinski T, et al. Autoantibodies in autoimmune liver disease—clinical and diagnostic relevance. Front Immunol. 2018;9:609. doi: 10.3389/fimmu.2018.00609.
   PubMed Web of Science ®Google Scholar
• Eng K, Lopez R, Liccardo D, et al. A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease. Dig Liver Dis. 2014;46(11):1008–1013. doi: 10.1016/j.dld.2014.07.016.
   PubMedGoogle Scholar
• Harrell FE, Jr., Califf RM, Pryor DB, et al. Evaluating the yield of medical tests. JAMA 1982;247(18):2543–2546. doi: 10.1001/jama.1982.03320430047030.
   PubMed Web of Science ®Google Scholar
• de Boer YS, van Nieuwkerk CM, Witte BI, et al. Assessment of the histopathological key features in autoimmune hepatitis. Histopathology. 2015;66(3):351–362. doi: 10.1111/his.12558.
   PubMed Web of Science ®Google Scholar
• Gordon V, Adhikary R, Appleby V, et al. Diagnosis, presentation and initial severity of autoimmune hepatitis (AIH) in patients attending 28 hospitals in the UK. Liver Int. 2018;38(9):1686–1695. doi: 10.1111/liv.13724.
   PubMed Web of Science ®Google Scholar
• Sebode M, Hartl J, Vergani D, et al. Autoimmune hepatitis: from current knowledge and clinical practice to future research agenda. Liver Int. 2018;38(1):15–22. doi: 10.1111/liv.13458.
   PubMed Web of Science ®Google Scholar
• Mieli-Vergani G, Vergani D, Czaja AJ, et al. Autoimmune hepatitis. Nat Rev Dis Primers. 2018;4:18017. doi: 10.1038/nrdp.2018.17.
   PubMed Web of Science ®Google Scholar
• Lenti MV, Rossi CM, Melazzini F, et al. Seronegative autoimmune diseases: a challenging diagnosis. Autoimmun Rev. 2022;21(9):103143. doi: 10.1016/j.autrev.2022.103143.
   PubMed Web of Science ®Google Scholar
• Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology. 2009;49(3):1017–1044. doi: 10.1002/hep.22742.
   PubMed Web of Science ®Google Scholar
• Mieli-Vergani G, Zen Y, Vergani D. Reassessement of the histological features of autoimmune hepatitis. Liver Int. 2022;42(5):954–956. doi: 10.1111/liv.15219.
   PubMed Web of Science ®Google Scholar
• Gatselis NK, Zachou K, Koukoulis GK, et al. Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol. 2015;21(1):60–83. doi: 10.3748/wjg.v21.i1.60.
   PubMed Web of Science ®Google Scholar
• Qiu DK. [Importance on the early diagnosis and treatment of autoimmune hepatitis.] Zhonghua Gan Zang Bing Za Zhi. 2012;20:321–323.
   PubMedGoogle Scholar
• Anastasiou OE, Dogan-Cavus B, Kucukoglu O, et al. Corticosteroid therapy improves the outcome of autoimmune hepatitis-induced acute liver failure. Digestion. 2018;98(2):104–111. doi: 10.1159/000487940.
   PubMed Web of Science ®Google Scholar
• Kirstein MM, Metzler F, Geiger E, et al. Prediction of short- and long-term outcome in patients with autoimmune hepatitis. Hepatology. 2015;62(5):1524–1535. doi: 10.1002/hep.27983.
   PubMed Web of Science ®Google Scholar
• Biewenga M, Verhelst X, Baven-Pronk M, et al. Development and validation of a prognostic score for long-term transplant-free survival in autoimmune hepatitis type 1. Unit Eur Gastroenterol J. 2021;9(6):662–671. doi: 10.1002/ueg2.12112.
   PubMed Web of Science ®Google Scholar